The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa.
CD55
Helicobacter pylori
decay-accelerating factor
gastric cancer
intestinal metaplasia
vacuolating cytotoxin
virulence factor
Journal
The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
27
06
2022
received:
10
01
2022
accepted:
15
07
2022
pubmed:
20
7
2022
medline:
9
9
2022
entrez:
19
7
2022
Statut:
ppublish
Résumé
High-level expression of decay-accelerating factor, CD55, has previously been found in human gastric cancer (GC) and intestinal metaplasia (IM) tissues. Therapeutic effects of CD55 inhibition in cancer have been reported. However, the role of Helicobacter pylori infection and virulence factors in the induction of CD55 and its association with histological changes of the human gastric mucosa remain incompletely understood. We hypothesised that CD55 would be increased during infection with more virulent strains of H. pylori, and with more marked gastric mucosal pathology. RT-qPCR and immunohistochemical analyses of gastric biopsy samples from 42 H. pylori-infected and 42 uninfected patients revealed that CD55 mRNA and protein were significantly higher in the gastric antrum of H. pylori-infected patients, and this was associated with the presence of IM, but not atrophy, or inflammation. Increased gastric CD55 and IM were both linked with colonisation by vacA i1-type strains independently of cagA status, and in vitro studies using isogenic mutants of vacA confirmed the ability of VacA to induce CD55 and sCD55 in gastric epithelial cell lines. siRNA experiments to investigate the function of H. pylori-induced CD55 showed that CD55 knockdown in gastric epithelial cells partially reduced IL-8 secretion in response to H. pylori, but this was not due to modulation of bacterial adhesion or cytotoxicity. Finally, plasma samples taken from the same patients were analysed for the soluble form of CD55 (sCD55) by ELISA. sCD55 levels were not influenced by IM and did not correlate with gastric CD55 mRNA levels. These results suggest a new link between active vacA i1-type H. pylori, IM, and CD55, and identify CD55 as a molecule of potential interest in the management of IM as well as GC treatment. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Identifiants
pubmed: 35851954
doi: 10.1002/path.5990
pmc: PMC9543990
doi:
Substances chimiques
Antigens, Bacterial
0
Bacterial Proteins
0
CD55 Antigens
0
Cytotoxins
0
RNA, Messenger
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
199-209Subventions
Organisme : Medical Research Council
ID : G0601170
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R026343/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N001826/1
Pays : United Kingdom
Informations de copyright
© 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Références
Innate Immun. 2017 Feb;23(2):165-174
pubmed: 27913793
J Biol Chem. 2004 Feb 20;279(8):7024-8
pubmed: 14630932
Gut. 2019 Sep;68(9):1545-1575
pubmed: 31278206
Gastrointest Endosc. 2010 Jun;71(7):1150-8
pubmed: 20381801
Oncol Rep. 2019 Dec;42(6):2686-2693
pubmed: 31578581
Gastroenterology. 2002 Mar;122(3):689-96
pubmed: 11875002
Int J Cancer. 2013 Sep 1;133(5):1023-32
pubmed: 23280711
J Infect Dis. 2014 Sep 15;210(6):954-63
pubmed: 24625807
J Biol Chem. 2008 Aug 29;283(35):23922-30
pubmed: 18579524
Gastroenterology. 2007 Sep;133(3):926-36
pubmed: 17854597
Cancer Lett. 2002 Feb 8;176(1):47-55
pubmed: 11790453
Gut. 1998 Apr;42(4):522-9
pubmed: 9616315
Annu Rev Pathol. 2021 Jan 24;16:123-144
pubmed: 33197219
Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1431-41
pubmed: 23929249
Gastric Cancer. 2016 Jan;19(1):166-75
pubmed: 25609452
Gut. 2014 Oct;63(10):1550-9
pubmed: 24436142
Infect Immun. 2020 Jan 22;88(2):
pubmed: 31712269
Front Immunol. 2021 Jan 05;11:599647
pubmed: 33469456
J Biol Chem. 1995 Jul 28;270(30):17771-7
pubmed: 7629077
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Histopathology. 2002 Apr;40(4):339-47
pubmed: 11943018
Biochem Biophys Res Commun. 2002 Jun 7;294(2):470-9
pubmed: 12051735
Oncol Rep. 2014 Mar;31(3):1059-66
pubmed: 24452482
J Biol Chem. 2001 Jun 15;276(24):21885-94
pubmed: 11283019
Gastroenterology. 2008 Jul;135(1):91-9
pubmed: 18474244
J Med Microbiol. 2020 Feb;69(2):218-227
pubmed: 32011229
Endoscopy. 2019 Apr;51(4):365-388
pubmed: 30841008
Adv Exp Med Biol. 2021;1302:25-39
pubmed: 34286439
Gastroenterology. 2005 Nov;129(5):1807-8
pubmed: 16285989
Immune Netw. 2018 Feb 20;18(1):e11
pubmed: 29503741
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Helicobacter. 2019 Feb;24(1):e12544
pubmed: 30324717
Annu Rev Immunol. 1989;7:35-58
pubmed: 2469439
J Exp Med. 1987 Mar 1;165(3):848-64
pubmed: 2434600
Lancet. 1975 Jul 12;2(7924):58-60
pubmed: 49653
J Immunol. 2009 Dec 15;183(12):8099-109
pubmed: 20007577
PLoS Genet. 2010 Aug 19;6(8):e1001069
pubmed: 20808891
Gastroenterology. 2020 Feb;158(3):745-750
pubmed: 31887261
Curr Opin Gastroenterol. 2018 Nov;34(6):458-464
pubmed: 30138135
Ann Gastroenterol. 2017;30(4):414-423
pubmed: 28655977
Histopathology. 1998 Dec;33(6):554-60
pubmed: 9870151
J Biol Chem. 2003 Jul 18;278(29):26734-41
pubmed: 12738773
J Biol Chem. 2006 May 12;281(19):13317-13323
pubmed: 16543227
Am J Surg Pathol. 1996 Oct;20(10):1161-81
pubmed: 8827022
J Natl Cancer Inst. 2007 Sep 5;99(17):1328-34
pubmed: 17728213
J Biol Chem. 2006 Apr 28;281(17):11637-48
pubmed: 16513653
Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G635-47
pubmed: 18096609
J Exp Med. 2005 Feb 21;201(4):567-77
pubmed: 15710649
Gastroenterology. 2004 Aug;127(2):514-23
pubmed: 15300584
J Gastroenterol Hepatol. 2005 Sep;20(9):1344-51
pubmed: 16105119
J Immunol. 2006 Jul 15;177(2):1070-7
pubmed: 16818763